Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Other hematologic neoplasm 1Myeloid 1

Conditions

Myelodysplastic Syndromes 1Multiple Myeloma 1Leukemia 1Hematologic Diseases 1Graft vs Host Disease 1

Interventions

Cyclosporine 5Cyclophosphamide 5Peripheral Blood Stem Cell Transplantation 3Methotrexate 3Busulfan 3Antilymphocyte Serum 3fludarabine phosphate 2Tacrolimus 2Sirolimus 2Radiotherapy 2Mycophenolic Acid 2Filgrastim 2prostaglandin D2 receptor 1merphos 1fludarabine 1Vorinostat 1Voriconazole 1Transplantation 1Thalidomide 1Stem Cell Transplantation 1RFT5-SMPT-dgA immunotoxin 1Polymerase Chain Reaction 1Pentostatin 1Neoadjuvant Therapy 1Methylprednisolone 1Lymphocyte Depletion 1Kidney Transplantation 1Immunoenzyme Techniques 1Granulocyte-Macrophage Colony-Stimulating Factor 1Granulocyte Colony-Stimulating Factor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
NIH × Graft vs Host Disease × Fluconazole × Clear all
NCT00023530 2016-02-18

Blood and Marrow Transplant Clinical Research Network

National Heart, Lung, and Blood Institute (NHLBI)

Phase NA Completed
MyeloidOther hematologic neoplasmPlasma cell

Graft vs Host Disease, Hematologic Diseases, Leukemia, Multiple Myeloma, Myelodysplastic Syndromes

Data powered by HemOnc (CC BY 4.0) Colophon âš¡